• Nasdaq notified GlucoTrack on October 28, 2026, that its securities would be delisted for failing to meet minimum bid price requirements.
• Trading in its common stock on Nasdaq will be suspended at the open on October 30, 2026.
• The closing bid price of $0.87 on October 14, 2026, breached the exception granted under Nasdaq Listing Rule 5550(a)(2).
• The exception required a closing bid price of at least $1 each trading day through November 9, 2026.
• The company expects its common stock to be quoted on OTC Markets upon suspension, with an application planned for the OTCID Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-049299), on October 29, 2026, and is solely responsible for the information contained therein.